Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Central Baptist receives ACTION Registry–GWTG Platinum Performance Achievement Award

Central Baptist Hospital is one of only 164 hospitals nationwide to receive the American College of Cardiology Foundation's NCDR ACTION Registry–Get With The Guidelines Platinum Performance Achievement Award for 2012.

9 Oct 2012

Beta blockers do not lower cardiac risk in patients with or without CAD

Beta-blocker therapy does not reduce the risk for cardiovascular events in patients with or without coronary artery disease, researchers say.

4 Oct 2012

Beta-blockers not associated with reduced risk of heart attacks, death and strokes

A new study conducted by researchers in the Cardiac and Vascular Institute at NYU Langone Medical Center, found using beta-blockers, the standard of care for patients with coronary artery disease (CAD), was not associated with a lower risk of heart attacks, death and strokes in patients suffering from CAD and those with risk factors for the disease, including those with a history of heart attack.

4 Oct 2012

Beta blockers do not lower cardiac risk in patients with or without CAD

Beta-blocker therapy does not reduce the risk for cardiovascular events in patients with or without coronary artery disease, researchers say.

3 Oct 2012

Beta-blockers do not appear to reduce risk of cardiovascular events in patients with CAD

Among patients with either coronary artery disease (CAD) risk factors only, known prior heart attack, or known CAD without heart attack, the use of beta-blockers was not associated with a lower risk of a composite of cardiovascular events that included cardiovascular death, nonfatal heart attack or nonfatal stroke, according to a study in the October 3 issue of JAMA.

3 Oct 2012

Eating apples might help keep the cardiologist away

Eating an apple a day might in fact help keep the cardiologist away, new research suggests.

3 Oct 2012

STENTYS announces European commercial release of new Self-Apposing stent technology

STENTYS, a medical technology company commercializing the world's first and only self-apposing stent to treat Acute Myocardial Infarction (AMI), announced today the European commercial release of an enhanced stent-delivery system for its Self-Apposing stent.

27 Sep 2012

Enrollment complete in Resverlogix‘s RVX-208 Phase 2b trial on cardiovascular disease

Resverlogix Corp. today announced that it has completed enrollment in ASSURE, a Phase 2b clinical trial targeting high-risk cardiovascular disease patients.

27 Sep 2012

GSK3 inhibition protects against gum disease

Treatment with the cell-permeable glycogen synthase kinase -3β-specific enzyme inhibitor SB216763 successfully suppresses alveolar bone loss in mice infected with the main periodontal pathogen, Porphyromonas gingivalis, report researchers.

20 Sep 2012

FDA Division of Neurology Products, CoLucid reach agreement for lasmiditan development strategy

CoLucid Pharmaceuticals, Inc., a privately held biopharmaceutical company, has reached agreement with the Food and Drug Administration's Division of Neurology Products concerning the development strategy for lasmiditan at a recently completed End of Phase 2 meeting.

19 Sep 2012

Dabigatran increasingly being used off-label

Dabigatran has increasingly been used for off-label indications, including venous thromboembolism, in the USA between 2007 and 2011, a study suggests.

13 Sep 2012

Silent infarcts prognostic in young stroke patients

Silent ischemic lesions are common and are associated with a high rate of recurrent events in young patients with acute ischemic stroke, report researchers.

12 Sep 2012

Exercise and health: An interview with Professor Karim Khan

I’ll quote from the ‘7 investments’ document (see below) as I don’t believe we need to reinvent the wheel to argue for the benefits of exercise. I am very keen to move to the issue of ‘how can we help people exercise’. But for the record:

12 Sep 2012

Baylor Health Care System raises awareness about atrial fibrillation

An estimated 2.5 million Americans suffer from irregular heartbeats-also known as atrial fibrillation. Baylor Health Care System is raising awareness about this often misunderstood, but potentially life changing cardiovascular condition whose incidence is on the rise and expected to more than double by 2050.

10 Sep 2012

CAD risk no higher in head and neck cancer

Researchers have shown that people with head or neck cancer are not necessarily at any greater risk for developing coronary artery disease than the general population.

4 Sep 2012

Tunes and T-shirts for cardiac rehabilitation

Two studies presented at the European Society of Cardiology Congress in Munich, Germany, showed how researchers are developing innovative approaches to help patients get the most out of cardiac rehabilitation.

31 Aug 2012

Fractional flow reserve CT shows potential to non-invasively identify coronary artery disease

A study published in the most recent issue of the Journal of the American Medical Association (JAMA) presented encouraging news regarding physicians' ability to determine blood flow and associated coronary artery disease (CAD) using noninvasive CT scanning technology.

30 Aug 2012

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Central Baptist receives ACTION Registry–GWTG Platinum Performance Achievement Award

Beta blockers do not lower cardiac risk in patients with or without CAD

Beta-blockers not associated with reduced risk of heart attacks, death and strokes

Beta blockers do not lower cardiac risk in patients with or without CAD

Beta-blockers do not appear to reduce risk of cardiovascular events in patients with CAD

Eating apples might help keep the cardiologist away

STENTYS announces European commercial release of new Self-Apposing stent technology

Enrollment complete in Resverlogix‘s RVX-208 Phase 2b trial on cardiovascular disease

GSK3 inhibition protects against gum disease

FDA Division of Neurology Products, CoLucid reach agreement for lasmiditan development strategy

Dabigatran increasingly being used off-label

Silent infarcts prognostic in young stroke patients

Exercise and health: An interview with Professor Karim Khan

Baylor Health Care System raises awareness about atrial fibrillation

CAD risk no higher in head and neck cancer

Tunes and T-shirts for cardiac rehabilitation

Fractional flow reserve CT shows potential to non-invasively identify coronary artery disease

Tunes and T-shirts for cardiac rehabilitation

Mortality risk similar for White vs Black diabetics

Study finds decline in 30-day mortality of acute myocardial infarction with improved treatment

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in